NIFTY 50▲24,834.85
428.75 (1.76%)
SENSEX▲81,332.72
1292.92 (1.62%)
NIFTY BANK▲51,295.95
407.20 (0.80%)
INDIAN RAILWAY FINANCE CORP▼183.44
-0.12 (-0.07%)
TATA MOTORS▲1,118.30
27.35 (2.51%)
TATA STEEL▲162.55
5.16 (3.28%)
TATA POWER▲444.70
21.35 (5.04%)
SUZLON ENERGY▲61.89
0.42 (0.68%)
RAIL VIKAS NIGAM▼552.35
-23.35 (-4.06%)
INDIAN RENEWABLE ENERGY▼258.03
-3.15 (-1.21%)
VODAFONE IDEA▲15.98
0.80 (5.27%)
RELIANCE INDUSTRIES▲3,018.05
33.25 (1.11%)
YES BANK▲24.97
0.35 (1.42%)
ADANI POWER▲712.65
17.45 (2.51%)
NHPC▲104.62
2.66 (2.61%)
STATE BANK OF INDIA▲862.45
13.95 (1.64%)
HDFC BANK▲1,618.15
1.55 (0.10%)
RELIANCE POWER▲29.77
0.08 (0.27%)
JIO FIN SERVICES LTD▲331.90
2.70 (0.82%)
ZOMATO▲224.62
5.31 (2.42%)
ADANI PORT & SEZ▲1,542.75
55.75 (3.75%)
BHARAT ELECTRONICS▲309.90
8.45 (2.80%)
INDIAN RAILWAY TOURISM CORP▲984.15
15.00 (1.55%)
INDIAN OIL CORP▼176.55
-0.30 (-0.17%)
RATTANINDIA POWER▲16.87
0.06 (0.36%)
MRF▲1,38,870.35
1280.25 (0.93%)
ADANI ENTERPRISES▲3,080.50
107.00 (3.60%)
JAIPRAKASH POWER VENTURES▲19.66
0.83 (4.41%)
![stock logo](https://assets.upstox.com/content/assets/images/logos/NSE_EQ|INE0LRU01027.png)
Aarti Pharmalabs Share Price
AARTIPHARM
₹605.20+₹18.90 (3.22%) TodayLast updated on 26 Jul, 2024 | 15:42 IST
₹583.65₹606.70
L
H
What’s in news?
Company overview
Financial performance
Market cap
| Open₹587.25 | Close₹586.30 |
Circuit range₹703.55 - ₹469.05 | Day range₹583.65 - ₹606.70 | Year range₹330.05 - ₹662.80 |
Volume1,66,915 | Avg. traded₹600.80 | Revenue (12m)₹1,853 Crs |
Aarti PharmalabsAarti Pharmalabs Limited is a manufacturer of active pharmaceutical ingredients (API), pharmaceutical intermediates, new chemical entities (NCE), xanthine derivatives, and allied products, situated in India. The Company delivers contract development and manufacturing organization (CDMO) services for drug substance/NCE development and manufacturing for pharmaceutical and biotech firms with a focus on the Ph-I/II/III, launch, and commercial phases. It has dedicated facilities for the production of corticosteroids, cytotoxic medicines, and oncology products. Its range of API products include Ramipril, Quinapril HCL, Budesonide, Bambuterol HCL, Apixaban, Rivaroxaban, Cinacalcet and others. Its range of intermediate products include Abemaciclib Intermediate, Acalabrutinib Intermediate, Afatinib Intermediate, Apalutamide Intermediate, Azathioprine Intermediate, and others. Its Caffeine products include caffeine anhydrous, and caffeine anhydrous (granules).
Aarti Pharmalabs Key indicators
52 week high₹662.80 | 52 week low₹330.05 | P/E ratio23.86 |
P/B ratio3.03 | ROE13.11% | ROCE16.55% |
Dividend yield0.51% | Debt/Equity ratio0.15 | EPS22.14 |
Learn more
Featured in
Investment checklist: (2/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Fundamentals
Financial ratios
Operating profit margin23.78% | Net profit margin13.36% |
ROE13.11% | ROA9.39% |
ROCE16.55% |
Learn more
Aarti Pharmalabs Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Thu, Jul 25 2024 | ₹578.55 | ₹586.30 | |
Wed, Jul 24 2024 | ₹571.25 | ₹578.55 | |
Tue, Jul 23 2024 | ₹572.90 | ₹571.25 | -1.18% |
Mon, Jul 22 2024 | ₹565.05 | ₹578.10 | |
Fri, Jul 19 2024 | ₹610.00 | ₹577.75 | -7.82% |
Thu, Jul 18 2024 | ₹612.00 | ₹626.75 | |
Tue, Jul 16 2024 | ₹609.00 | ₹608.90 | |
Mon, Jul 15 2024 | ₹610.95 | ₹606.85 | -0.27% |
Events
Corporate actions
Dividend • ₹1/share
Ex date 31 Jul 2024
Dividend • ₹2/share
Ex date 16 Feb 2024
Dividend • ₹2/share
Ex date 17 Jan 2023
Learn more